Key result
Coadministration of dabigatran etexilate and digoxin did not significantly alter the pharmacokinetics or pharmacodynamics of either drug, indicating no dose adjustment is needed.
Why the study?
Does coadministration of digoxin alter the pharmacokinetics and pharmacodynamics of dabigatran etexilate in healthy volunteers?
Does coadministration of digoxin alter the pharmacokinetics and pharmacodynamics of dabigatran etexilate in healthy volunteers?
Dabigatran etexilate and digoxin can be coadministered without the need for dose adjustment of either drug, as there are no significant pharmacokinetic or pharmacodynamic interactions.
Answers are grounded in this paper and cite their sources.
Supports coadministration without dose adjustment in healthy volunteers; leaves open confirmation in patients with cardiovascular disease.
This study evaluated the potential impact of concomitant digoxin on the pharmacokinetics and pharmacodynamics of dabigatran etexilate, a novel oral direct thrombin inhibitor. Healthy volunteers (n = 23) received 150 mg dabigatran etexilate twice daily on days 1 to 3 and once on day 4 in 1 period. Digoxin was given in another period as a loading dose of 0.5 mg early on day 1 and 0.25 mg in the evening of day 1 and on the mornings of days 2 to 4. In a third treatment period, dabigatran etexilate together with digoxin was given on days 1 to 4. Exposure to dabigatran was not significantly altered with concomitant digoxin-the maximum concentration (Cmax,ss ) and area under the concentration-time curve at steady state over 1 dosing interval (AUCτ,ss ) of dabigatran with and without digoxin were essentially unchanged. The pharmacokinetic profile of digoxin also remained unchanged in the presence of dabigatran etexilate. Dabigatran's anticoagulant effect, assessed by blood coagulation time assays, was not influenced by digoxin. Dabigatran etexilate and digoxin can be coadministered without the need for dose adjustment of either drug.
No takes yet. Share an insight, caveat, or question.
Stangier et al. (2011) studied Healthy volunteers (n=23). Dabigatran etexilate and digoxin coadministration vs. Dabigatran alone and digoxin alone was evaluated on Pharmacokinetics (Cmax,ss and AUCτ,ss) and pharmacodynamics (blood coagulation time). Coadministration of dabigatran etexilate and digoxin did not significantly alter the pharmacokinetics or pharmacodynamics of either drug, indicating no dose adjustment is needed.
Synapse has enriched 10 related papers. Consider them for comparative context: